Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients.

Fiche publication


Date publication

janvier 2013

Journal

BMC infectious diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DUVILLARD Laurence, Pr ORNETTI Paul


Tous les auteurs :
Ansemant T, Mahy S, Piroth C, Ornetti P, Ewing S, Guilland JC, Croisier D, Duvillard L, Chavanet P, Maillefert JF, Piroth L

Résumé

Even though it has been suggested that antiretroviral therapy has an impact on severe hypovitaminosis D (SHD) in HIV infected patients, it could be speculated that the different levels of residual inflammation on HAART (Highly Active Anti Retroviral Therapy) could contribute to SHD and aggravate bone catabolism in these patients.

Mots clés

Adult, Aged, Antiretroviral Therapy, Highly Active, Biomarkers, metabolism, Bone and Bones, metabolism, Female, HIV Infections, complications, Humans, Inflammation Mediators, metabolism, Male, Middle Aged, Risk Factors, Vitamin D Deficiency, etiology, Young Adult

Référence

BMC Infect. Dis.. 2013 Jan;13:7